Document is current
Any future updates will be listed below
-
Authors
Chiloiro, Giuditta
Cusumano, Davide
Boldrini, Luca
Romano, Angela http://orcid.org/0000-0001-9371-9951
Placidi, Lorenzo
Nardini, Matteo
Meldolesi, Elisa
Barbaro, Brunella
Coco, Claudio
Crucitti, Antonio
Persiani, Roberto
Petruzziello, Lucio
Ricci, Riccardo
Salvatore, Lisa
Sofo, Luigi
Alfieri, Sergio
Manfredi, Riccardo
Valentini, Vincenzo
Gambacorta, Maria Antonietta
-
Funding
Funding for this research was provided by:
viewray inc
- License Information
-
More Information
Article History
Received: 21 June 2021
Accepted: 24 December 2021
First Online: 15 January 2022
Declarations
:
: The protocol was approved by the Ethics Committee of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS on 19 November 2020 (ethics committee identifier code 3460). Prior to inclusion in the trial, each patient will personally sign and date a written informed consent.
: All patients recruited in the study will sign informed consent regarding publishing their data.
: Dr. Luca Boldrini and Dr. Davide Cusumano have active research agreements with ViewRay Inc (Mountain View, CA, USA). and received speaker honoraria for scientific presentations and travel reimbursements. Prof. Vincenzo Valentini has received departmental research grants from Varian Medical Systems, ViewRay Inc., Elekta, Merck-Serono, Roche. Prof. Riccardo Manfredi received speaker honoraria from Bracco and Bayer. Dr. Lisa Salvatore received speaker, advisory board and consultancy honoraria from Amgen, Merck, Bayer, Servier, AstraZeneca, Pierre-Fabre. Dr. Lorenzo Placidi reports a consulting agreement and research grants with ViewRay, outside the submitted work.
